E & R Ventures

Eir Ventures is a Nordic-based venture capital firm dedicated to investing in and developing innovative life science companies, primarily in the Nordics but with a global perspective. The firm focuses on early- to growth-stage biotech and healthcare companies, leveraging deep scientific expertise and an active ownership model. Eir Ventures aims to bridge the gap between Nordic scientific innovation and available venture capital, with a particular focus on therapeutic areas such as endocrinology, neuroscience, stem cells, oncology, and peptide/oligonucleotide drugs. The company’s investment triad emphasizes transformative potential, excellence in execution, and scalability for all portfolio companies[1][3][5].